Anaeropharma Science will be presenting its latest research outcomes regarding agonistic antibody producing recombinant Bifidobacterium at the 2018 Annual Meeting of the AACR

Anaeropharma Science will be presenting its latest research outcomes towards agonistic anti-4-1BB scFv antibody producing recombinant Bifidobacterium at the 2018 Annual Meeting of the AACR (American Association for Cancer Research), which takes place from April 14 to 18 in Chicago, the poster is titled Cancer immunotherapy with agonistic anti-4-1BB producing and secreting Bifidobacterium in syngeneic mouse model”, which will be presented on Apr. 16, from 1:00 PM to 5:00 PM, in the session of immune checkpoint 2.

Comments are closed.